5th Antwerp Biopharm Day
Discuss advances in R&D biopharmaceutical development and learn about the latest regulatory, early and late phase clinical trials solutions.
It is a great pleasure to invite you to the 5th SGS Life Sciences seminar.
The aim of this scientific meeting is to discuss advances in R&D biopharmaceutical development and learn the latest regulatory, early and late phase clinical trials solutions. This one-day event will include a selection of scientific talks, case studies and face-to-face meetings with some of our experts and key industry players such as:
- Maximizing Regional and European R&D Funding Possibilities
- FDA/EMA Inspection Readiness
- Sponsor/CRO and Venture Capitalist Approaches about How Regulators Perceive the Risk for a New Compound
- Phase I Studies: Moving from First Drug Design over First Pre-Clinical Data into First-In-Human Studies
- Innovative Hospital Partnership Model for High Quality Patient Clinical Trials
- Skipping Phase IIb Trials – Accelerating the Flu Pipeline – Proof of Efficacy from Human Challenge Trials
- How Biotech Companies Develop Innovative Therapies and Their Expectations from a CRO
- How Modeling and Simulation Can Optimize a Clinical Trial
For further information, please contact:
Wendy Crauwels
SGS - Clinical Research
t: +32 15 40 50 82